(b)(4).The device was returned for analysis.The reported detachment of a device component was confirmed.The reported deflation issues and difficulty to remove could not be confirmed as the device condition prevented any functional testing from being performed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.A cine was received and reviewed by an abbott vascular clinical specialist.The reviewer concluded it is noted within the images provided that the stent system balloon used to treat the proximal lad did not fully deflate.It appears that the distal end of the stent system is irregularly shaped.The initial inflation was done at 15:50.The last image received was timed at 16:25.This means that the balloon was partially inflated in the proximal lad for a minimum of 35 minutes.It is seen that attempts were made to re-inflate and deflate the balloon.The reported patient effects of angina, fever and death are listed in the xience prime, everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.The investigation was unable to determine a conclusive cause for the reported deflation issues; however, the difficulty to remove and detachment of a device component with the patient effects of angina appear to be related to operational context of the procedure.Additionally, the investigation was unable to determine a conclusive cause for the reported patient effects of fever and death, and the relationship to the device, if any.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|